Imaging in Cancer Drug Development
7 - 8 Mar 2011
Copthorne Tara Hotel, London, United Kingdom of Great Britain and Northern Ireland
SMi is proud to present the 7th annual conference in its series on imaging for the purposes of developing novel cancer therapies. Imaging in Cancer Drug Development 2011 will build on the success of the previous 6 years to bring your knowledge in this field in line with the latest developments.
Attend this event to learn how best to use imaging techniques to expedite your oncology drug development process.
Including key presentations from:
• Helen Young, Imaging Specialist, AstraZeneca
• Jan Passchier, Director, PET and Radiochemistry, GlaxoSmithKline
• Werner Scheuer, Group Leader, Preclinical Optical Imaging, Pharmacology TR-PD, Pharmaceutical Research, Roche
• Rainer Kneuer, Investigator III, Novartis Institutes for Biomedical Research
No items were found.
